Eichler HG - Search Results

1

Transparency and the European Medicines Agency--sharing of clinical trial data.

Bonini S, Eichler HG, Wathion N, Rasi G. Bonini S, et al. Among authors: eichler hg. N Engl J Med. 2014 Dec 25;371(26):2452-5. doi: 10.1056/NEJMp1409464. N Engl J Med. 2014. PMID: 25539105 Free article. No abstract available.

2

Drug Regulation and Pricing--Can Regulators Influence Affordability?

Eichler HG, Hurts H, Broich K, Rasi G. Eichler HG, et al. N Engl J Med. 2016 May 12;374(19):1807-9. doi: 10.1056/NEJMp1601294. N Engl J Med. 2016. PMID: 27168431 No abstract available.

3

Drug policy for an aging population--the European Medicines Agency's geriatric medicines strategy.

Cerreta F, Eichler HG, Rasi G. Cerreta F, et al. Among authors: eichler hg. N Engl J Med. 2012 Nov 22;367(21):1972-4. doi: 10.1056/NEJMp1209034. N Engl J Med. 2012. PMID: 23171092 No abstract available.

4

Access to patient-level trial data--a boon to drug developers.

Eichler HG, Pétavy F, Pignatti F, Rasi G. Eichler HG, et al. N Engl J Med. 2013 Oct 24;369(17):1577-9. doi: 10.1056/NEJMp1310771. Epub 2013 Oct 21. N Engl J Med. 2013. PMID: 24144395 Free article. No abstract available.

5

Clinical trial publications: A sufficient basis for healthcare decisions?

Eichler HG, Rasi G. Eichler HG, et al. Eur J Intern Med. 2020 Jan;71:13-14. doi: 10.1016/j.ejim.2019.11.022. Epub 2020 Jan 14. Eur J Intern Med. 2020. PMID: 31948774 No abstract available.

6

Increasing the impact of Post Authorisation Safety Studies: transparency is key.

Kurz X, Arlett P, Eichler HG, Nolte A, Straus S, Rasi G. Kurz X, et al. Among authors: eichler hg. Eur J Intern Med. 2021 Jan;83:6-7. doi: 10.1016/j.ejim.2020.11.019. Epub 2020 Dec 1. Eur J Intern Med. 2021. PMID: 33277138 No abstract available.

7

Open clinical trial data for all? A view from regulators.

Eichler HG, Abadie E, Breckenridge A, Leufkens H, Rasi G. Eichler HG, et al. PLoS Med. 2012;9(4):e1001202. doi: 10.1371/journal.pmed.1001202. Epub 2012 Apr 10. PLoS Med. 2012. PMID: 22505851 Free PMC article.

8

Are Novel, Nonrandomized Analytic Methods Fit for Decision Making? The Need for Prospective, Controlled, and Transparent Validation.

Eichler HG, Koenig F, Arlett P, Enzmann H, Humphreys A, Pétavy F, Schwarzer-Daum B, Sepodes B, Vamvakas S, Rasi G. Eichler HG, et al. Clin Pharmacol Ther. 2020 Apr;107(4):773-779. doi: 10.1002/cpt.1638. Epub 2019 Oct 1. Clin Pharmacol Ther. 2020. PMID: 31574163 Free PMC article. Review.

9

Clinical Trials for COVID-19: Can we Better Use the Short Window of Opportunity?

Eichler HG, Cavaleri M, Enzmann H, Scotti F, Sepodes B, Sweeney F, Vamvakas S, Rasi G. Eichler HG, et al. Clin Pharmacol Ther. 2020 Oct;108(4):730-733. doi: 10.1002/cpt.1891. Epub 2020 Jun 12. Clin Pharmacol Ther. 2020. PMID: 32407539 Free PMC article. Review.

10

European regulatory experience with drugs for central nervous system disorders.

Butlen-Ducuing F, Zienowicz M, Pétavy F, Haas M, Salmonson T, Eichler HG, Rasi G. Butlen-Ducuing F, et al. Among authors: eichler hg. Nat Rev Drug Discov. 2015 Feb;14(2):89-90. doi: 10.1038/nrd4511. Epub 2014 Dec 19. Nat Rev Drug Discov. 2015. PMID: 25524018 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

338 results

Search Page